Thrombosis Journal

Papers
(The median citation count of Thrombosis Journal is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Two cases of venous thromboembolism in siblings after splenectomy due to a novel PROC gene mutation61
Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report56
Association between inflammatory indices and preoperative deep vein thrombosis in patients undergoing total joint arthroplasty: a retrospective study40
Relationship between serum uric acid levels and pulmonary embolism: an age-based stratified analysis30
The efficacy of tranexamic acid treatment with different time and doses for traumatic brain injury: a systematic review and meta-analysis29
Dietary zinc intake and 10-year atherosclerotic cardiovascular disease risk in diabetes mellitus patients: evidence from NHANES database26
Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study22
Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithms22
Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis20
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis20
Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?20
Investigating the dual causative pathways linking immune cells and venous thromboembolism via Mendelian randomization analysis19
The mechanisms of efficacy and safety of Ginkgo biloba extract in acute ischemic stroke: a real-world study18
Use of the RCOG risk assessment model and biomarkers to evaluate the risk of postpartum venous thromboembolism18
Risk of recurrent venous thromboembolism and major bleeding according to risk factor profiles in Asian patients: a subgroup analysis EINSTEIN-Extension and EINSTEIN-CHOICE18
Clinical significance of D-dimer levels during acute period in ischemic stroke17
Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow16
Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database16
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study15
Recurrent, life-threatening PE in the setting of popliteal vein aneurysm in pregnancy: a case report15
A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene15
A case of acquired thrombotic thrombocytopenic purpura induced by acute severe hepatitis E: successfully treated by plasma exchange and rituximab14
Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients14
Association between antithrombotic therapy and mortality in patients hospitalized for COVID‑1913
Association of elevated circulating monocyte-platelet aggregates with hypercoagulability in patients with nephrotic syndrome13
Serum interleukin 1β and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients? (a cross-sectional study)13
Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiecta12
The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study12
Effect of different balloon pressure band compression regimens on thrombolysis and lower limb venous blood flow velocity in patients undergoing anterograde thrombolysis via the superficial dorsalis pe12
Circular RNA ciRs-126 promotes hypoxia/reoxygenation cardiac injury possibly through miR-2111
A novel role for protein disulfide isomerase ERp18 in venous thrombosis11
Calibrated automated thrombogram II: removing barriers for thrombin generation measurements11
Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report11
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE11
Hyperlipidemia in immune thrombocytopenia: a retrospective study11
Utilization of the Caprini risk assessment model(RAM) to predict venous thromboembolism after primary hip and knee arthroplasty: an analysis of the Healthcare Cost and Utilization Project(HCUP)11
Association between red cell distribution width-to-lymphocyte ratio and 30-day mortality in patients with ischemic stroke: a retrospective cohort study11
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study11
Prognostic value of characteristics of plaque combined with residual syntax score among patients with STEMI undergoing primary PCI: an intravascular optical coherence tomography study11
An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention10
Damage-associated molecular patterns and fibrinolysis perturbation are associated with lethal outcomes in traumatic injury10
Circulating LPS from gut microbiota leverages stenosis-induced deep vein thrombosis in mice10
An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow10
Assessing outcomes after thrombectomy with or without iliac vein stenting for young provoked DVT patients with iliac vein stenosis10
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-1910
Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis9
The well-defined antiphospholipid syndrome induced by COVID-19: a rare case report and review of the literature9
The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines9
Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review9
Cancer incidence and mortality after a first-ever venous thrombosis: a cohort study in northern Sweden9
Coexistence of antithrombin deficiency and suspected inferior vena cava atresia in an adolescent and his mother – case report and clinical implications9
Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study9
The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China9
Role of ticagrelor in the peri-thrombolytic phase for patients with ST-segment elevation myocardial infarction: a comprehensive review9
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system8
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications8
Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes8
Factors associated with thrombosis among solid organ cancer patients in Kuala Lumpur, Malaysia8
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-198
Early coagulopathy after pediatric out-of-hospital cardiac arrest: secondary analysis of a randomized clinical trial8
Colonization of Fusobacterium nucleatum is an independent predictor of poor prognosis in gastric cancer patients with venous thromboembolism: a retrospective cohort study8
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy8
The disulfide bond Cys2724-Cys2774 in the C-terminal cystine knot domain of von Willebrand factor is critical for its dimerization and secretion8
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association8
Prevalence, risk, and outcome of deep vein thrombosis in acute respiratory distress syndrome8
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time7
Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study7
Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterolemia patients refractory to PCSK9 inhibitors: a case report and literature review7
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials7
Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trial7
Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study7
The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy7
Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors7
Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review7
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study6
The Buerger’s rabbit model: a closer step to unravelling thromboangiitis obliterans?6
Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study6
Effect of frozen storage conditions on antithrombin protein C and protein S activity assay stability6
Prevalence, predictors and management of left atrial appendage thrombogenic milieu in atrial fibrillation with low thromboembolic risk6
Venous thromboembolic disease in admitted blunt trauma patients: what matters?6
Predictors of pulmonary embolism in hospitalized patients with COVID-196
Prevalence and risk factor of post-operative lower extremities deep vein thrombosis in patients undergoing gynecologic surgery: a single-institute cross-sectional study6
Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus 26
A primary pulmonary artery sarcoma masquerading pulmonary embolism: a case report and literature review6
Development and external validation of prognostic scoring models for portal vein thrombosis: a multicenter retrospective study6
Anticoagulation may contribute to antimicrobial treatment of Lemierre syndrome: a case report6
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients6
How to exclude pulmonary embolism in patients hospitalized with COVID-19: a comparison of predictive scores6
Acute lower limb ischemia caused by vaccine-induced immune thrombotic thrombocytopenia: focus on perioperative considerations for 2 cases6
Heterozygosity for the Budapest 3 mutation in SERPINC1 in a family with thrombophilia and structural anomalies of the inferior vena cava6
The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country5
Correction to: agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage5
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis5
Causal effect of gut microbiota on venous thromboembolism: a two-sample mendelian randomization study5
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais5
Molecular patterns of alpha-thalassemia in the kingdom of Saudi Arabia: identification of prevalent genotypes and regions with high incidence5
The association of serum total bile acids and deep venous thrombosis5
Unprovoked venous thromboembolism recurrence and arterial embolism revealing lung cancer: a case report5
Insight into antiphospholipid syndrome: the role and clinical utility of neutrophils extracellular traps formation5
Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review5
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia5
Reduced mortality associated with pulmonary embolism response team consultation for intermediate and high-risk pulmonary embolism: a retrospective cohort study5
Renal damage and old age: risk factors for thrombosis in patients with ANCA-associated vasculitis5
The effect of neutrophil extracellular traps in venous thrombosis5
Cardiac thrombus in acute ischemic stroke: impact on endovascular thrombectomy utilization5
Low-density lipoprotein cholesterol-to-lymphocyte count ratio (LLR) is a promising novel predictor of postoperative new-onset deep vein thrombosis following open wedge high tibial osteotomy: a propens5
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia5
Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients5
Frontline use of rituximab may prevent ADAMTS13 inhibitor boosting during caplacizumab treatment in patients with iTTP: post hoc analysis of a phase 2/3 study in Japan5
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study5
A thrombophilia family with protein S deficiency due to protein translation disorders caused by a Leu607Ser heterozygous mutation in PROS15
Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report5
The role of Sphingomyelin synthase 2 (SMS2) in platelet activation and its clinical significance5
Cerebral venous sinus thrombosis associated with SRA-negative heparin-induced thrombocytopenia: case report5
Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudina5
Artificial intelligence in thrombosis: transformative potential and emerging challenges5
Correction to: The impact on renal function after longterm use of anticoagulants in atrial fibrillation patients5
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India4
GDF15 affects venous thrombosis by promoting EndMT through smad2/p-smad2 pathway4
Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis4
Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation combined with chronic kidney disease: a systematic review and meta-analysis4
A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score4
Incidence and risk factors of venous thrombotic events in patients with interstitial lung disease during hospitalization4
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study4
The evolution of clot strength in critically ill COVID-19 patients: a prospective observational thromboelastography study4
Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer4
Comparison between canine and porcine models of chronic deep venous thrombosis4
A catastrophic seronegative anti-phospholipid syndrome: case and literature review4
Insulin resistance, metabolic syndrome and micro-RNA-122 serum level in patients with cerebral venous sinus thrombosis: a case-control study4
Exercise transiently increases the density of incipient blood clots in antiplatelet-treated lacunar stroke patients4
Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome4
Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis4
The precision of ROTEM EXTEM is decreased in hypocoagulable blood: a prospective observational study4
Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System4
Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis4
Evaluation of the analytical performance of the PC100 platelet counter4
A prediction model for left ventricular thrombus persistence/recurrence: based on a prospective study and a retrospective study4
Monitoring coagulation-fibrinolysis activation prompted timely diagnosis of hemophagocytic lymphohistiocytosis-related disseminated intravascular coagulation4
Pregnancy and thrombosis risk for women without a history of thrombotic events: a retrospective study of the real risks3
“Y appearance” infarction: caused by essential thrombocythemia3
Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases3
Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis3
Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intens3
Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism3
Sex-related differences in the effect of rotational thrombectomy for thrombus-containing lower limbs ischemic lesions3
Postoperative intermittent pneumatic compression for preventing venous thromboembolism in Chinese lung cancer patients: a randomized clinical trial3
Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study3
Venous anomalies and thromboembolism3
Syndecan-1 as a prognostic biomarker in COVID-19 patients: a retrospective study of a Japanese cohort3
Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant3
The genetic causal relationship between type 2 diabetes, glycemic traits and venous thromboembolism, deep vein thrombosis, pulmonary embolism: a two-sample Mendelian randomization study3
Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background3
Application of a scoring system in Japanese patients diagnosed with atypical hemolytic uremic syndrome to assess the relationship between the score and clinical responses to eculizumab3
Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis3
The clinical application of venous ultrasound in diagnosis and follow-up of lower extremity deep vein thrombosis (DVT): a case-based discussion3
Coagulation abnormalities in childhood acute lymphoblastic leukemia: assessing the impact of L-asparaginase therapy in Ghana3
COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab3
A nomogram model for predicting preoperative DVT in elderly anemic patients undergoing total hip arthroplasty: a retrospective cohort study3
Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial3
Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT3
Clinical characteristics of venous thromboembolism onset from severe high altitude pulmonary edema in plateau regions3
Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic3
Implementation of early prophylaxis for deep-vein thrombosis in intracerebral hemorrhage patients: an observational study from the Chinese Stroke Center Alliance3
Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis3
Review article inferior vena cava thrombosis: a case series of patients observed in Taiwan and literature review3
LINC00659 exacerbates endothelial progenitor cell dysfunction in deep vein thrombosis of the lower extremities by activating DNMT3A-mediated FGF1 promoter methylation3
Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database3
Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model3
High-resolution magnetic resonance imaging-based radiomic features aid in selecting endovascular candidates among patients with cerebral venous sinus thrombosis3
Parapneumonic effusion is a risk factor for VTE in hospitalized patients with community-acquired pneumonia: a retrospective cohort study3
Monitoring the efficiency of reversal on anti-Xa direct oral anticoagulants using point-of-care viscoelastic testing3
Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review3
LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study2
External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a re2
Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study2
A review of thromboembolic events in hospitalized COVID-19 patients2
Bleeding complications following intramuscular injections among hospitalized anticoagulated patients: a retrospective observational comparative study2
Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study2
Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on2
Atrial fibrillation and anticoagulation are associated with hospitalisations in patients with end-stage kidney disease on haemodialysis: a prospective population-based cohort study2
The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study2
A single-center study of reference intervals for TAT, PIC, TM and t-PAIC in healthy older Chinese adults2
A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-192
Correspondence: Cancer incidence and mortality after a first-ever venous thrombosis in northern Sweden2
Nonnegligible causes of symptoms of acute lower extremities——3 cases of May-Thurner syndrome with deep vein thrombosis2
Comparison of anticoagulated versus non-anticoagulated patients with intra-aortic balloon pumps2
Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity2
Establishment and validation of a nomogram predicting the risk of deep vein thrombosis before total knee arthroplasty2
Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation2
Cerebral venous thrombosis at high altitude: more severe symptoms and specific predisposing factors than plain areas2
Causal association between circulating α-Klotho levels and venous thromboembolism: a two-sample Mendelian randomization study2
Preoperative coagulation biomarkers associate with survival and pulmonary embolism after surgical treatment of non-spinal skeletal metastases2
Restenosis after excimer laser coronary atherectomy and drug-coated balloon dilation in Takayasu’s arteritis: a case report and review of the literature2
Sources of bias and limitations of thrombinography: inner filter effect and substrate depletion at the edge of failure algorithm2
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis2
Risk factors and potential predictors of pulmonary embolism in cancer patients undergoing thoracic and abdominopelvic surgery: a case control study2
Causal relationship between varicose veins and mean corpuscular hemoglobin concentration based on Mendelian randomization study2
Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study2
Values and preferences towards the use of prophylactic low-molecular-weight heparin during pregnancy: a convergent mixed-methods secondary analysis of data from the decision analysis in shared decisio2
miR-1915-3p regulates megakaryocytic and erythroid differentiation by targeting SOCS42
Current and future strategies to monitor and manage coagulation in ECMO patients2
Coagulopathy and its associated factors among patients with a bleeding diathesis at the University of Gondar Specialized Referral Hospital, Northwest Ethiopia2
Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer2
Frequency of deep vein thrombosis at admission for acute stroke and associated factors: a cross-sectional study2
Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis2
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study2
Lemierre’s syndrome complicating deep neck abscess: a case report2
Recurrence in isolated distal DVT after anticoagulation: a systematic review and meta-analysis of axial and muscular venous thrombosis2
The efficacy of atorvastatin on inflammation and coagulation markers in high-risk thrombotic cancer patients undergoing chemotherapy: a randomized controlled trial2
A case-report of the unprovoked thrombotic event in a patient with thymoma and severe FVII deficiency2
Platelet-derived circFAM13B associated with anti-platelet responsiveness of ticagrelor in patients with acute coronary syndrome2
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data2
The magnitude and associated factors of coagulation abnormalities among liver disease patients at the University of Gondar Comprehensive Specialized Hospital Northwest, Ethiopia, 20222
Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study2
Additive prognostic value of serum calcium to the ESC risk stratification in patients with acute pulmonary embolism1
Acute caval thrombosis leading to obstructive shock in the early post insertion period of an inferior vena cava filter: a case report and literature review1
Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis1
Anticoagulation control for nonvalvular atrial fibrillation in a tertiary academic centre in Johannesburg1
Editorial expression of concern: Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis1
Gender-specific relationships between hyperuricemia and idiopathic deep venous thrombosis in the Chinese population: a case‒control study1
The transition of the criteria for disseminated intravascular coagulation and the targeted patients in randomized controlled trials over the decades: a scoping review1
Validation of a pulmonary embolism risk assessment model in gynecological inpatients1
Reply to correspondence: Cancer incidence and mortality after a first-ever venous thrombosis in northern Sweden1
Intercellular adhesion molecule 4 and ischemic stroke: a two-sample Mendelian randomization study1
Combination of graduated compression stockings and intermittent pneumatic compression is better in preventing deep venous thrombosis than graduated compression stockings alone for patients following g1
Spontaneous rectus sheath hematoma associated with apixaban in an elderly gentleman with chronic obstructive airway disease – a case report1
Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial1
Causal association between circulating blood cell traits and pulmonary embolism: a mendelian randomization study1
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency1
Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis1
Correlation between a 2-week change in platelet count and clinical outcomes after the initiation of ravulizumab treatment in adult patients with atypical hemolytic uremic syndrome: post-hoc analysis o1
Impact of extracorporeal membrane oxygenation treatments on acquired von Willebrand syndrome in patients with out-of-hospital cardiac arrest: a retrospective observational study1
Anatomical insights into the median septum on soleal vein network and deep vein thrombosis risk1
Deep venous thrombosis in an individual with statin-exposed anti-SRP myopathy: case report and review of literature1
Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients1
A 11-year-old boy with Blastocystis hominis infection, presents as immune thrombocytopenia1
Potential value of the calibrated automated thrombogram in patients after a cerebral venous sinus thrombosis; an exploratory study1
Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry1
Structure, signal transduction, activation, and inhibition of integrin αIIbβ31
Characterization of spreading depolarizations in swine following superior sagittal sinus occlusion: a novel gyrencephalic model study1
Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis1
Incidence of proximal deep vein thrombosis in medical critical care patients1
Clinical significance of neutrophil extracellular traps biomarkers in thrombosis1
Correction: The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study1
Longitudinal trajectories of atherogenic index of plasma and risks of cardiovascular diseases: results from the Korean genome and epidemiology study1
Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study1
Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study1
Successful retrieval of dislocated inferior vena cava filter using double vascular sheaths docking technology: case report1
Factors associated with bleeding events during catheter ablation with uninterrupted periprocedural edoxaban for atrial fibrillation: a subanalysis of the KYU-RABLE study1
Identification of key risk factors for venous thromboembolism in urological inpatients based on the Caprini scale and interpretable machine learning methods1
0.1940860748291